Lotilaner Ophthalmic Solution, 0.25% for Demodex Blepharitis: Phase 3 Trial (Saturn-2)

from AAOF Clinical Podcast Series · host American Academy of Optometry Foundation

Lotilaner Ophthalmic Solution, 0.25% for Demodex Blepharitis: Randomized, Vehicle- Controlled, Multicenter, Phase 3 Trial (Saturn-2) Hosted by: Andrew Pucker, OD, PhD, FAAO Topical Editor: Andrew Pucker, OD, PhD, FAAO Topical Expert: Patrick Vollmer, OD, FAAO - Tarsus Article: https://pubmed.ncbi.nlm.nih.gov/37285925/

Episode metadata supplied by the publisher feed · Published Feb 23, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Lotilaner Ophthalmic Solution, 0.25% for Demodex Blepharitis: Phase 3 Trial (Saturn-2)

0:00 6:04

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of AAOF Clinical Podcast Series?

This episode is 6 minutes long.

When was this AAOF Clinical Podcast Series episode published?

This episode was published on February 23, 2024.

Can I download this AAOF Clinical Podcast Series episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!